skip to main content
DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Metformin Treatment Inhibits Motility and Invasion of Glioblastoma Cancer Cells

Abstract

Glioblastoma multiforme (GBM) is one of the most common and deadliest cancers of the central nervous system (CNS). GBMs high ability to infiltrate healthy brain tissues makes it difficult to remove surgically and account for its fatal outcomes. To improve the chances of survival, it is critical to screen for GBM-targeted anticancer agents with anti-invasive and antimigratory potential. Metformin, a commonly used drug for the treatment of diabetes, has recently emerged as a promising anticancer molecule. This prompted us, to investigate the anticancer potential of metformin against GBMs, specifically its effects on cell motility and invasion. The results show a significant decrease in the survival of SF268 cancer cells in response to treatment with metformin. Furthermore, metformin’s efficiency in inhibiting 2D cell motility and cell invasion in addition to increasing cellular adhesion was also demonstrated in SF268 and U87 cells. Finally, AKT inactivation by downregulation of the phosphorylation level upon metformin treatment was also evidenced. In conclusion, this study provides insights into the anti-invasive antimetastatic potential of metformin as well as its underlying mechanism of action.

Authors:
ORCiD logo [1]; ORCiD logo [1];  [1];  [1];  [1]; ORCiD logo [1]; ORCiD logo [2]; ORCiD logo [1]
  1. Department of Natural Sciences, School of Arts and Sciences, Lebanese American University, Beirut, Lebanon
  2. Department of Biomedical Sciences, Faculty of Medicine and Medical Sciences, University of Balamand, El-Kurah, Lebanon
Publication Date:
Sponsoring Org.:
USDOE Office of Electricity (OE), Advanced Grid Research & Development. Power Systems Engineering Research
OSTI Identifier:
1457218
Resource Type:
Published Article
Journal Name:
Analytical Cellular Pathology
Additional Journal Information:
Journal Name: Analytical Cellular Pathology Journal Volume: 2018; Journal ID: ISSN 2210-7177
Publisher:
Hindawi Publishing Corporation
Country of Publication:
Country unknown/Code not available
Language:
English

Citation Formats

Al Hassan, Marwa, Fakhoury, Isabelle, El Masri, Zeinab, Ghazale, Noura, Dennaoui, Rayane, El Atat, Oula, Kanaan, Amjad, and El-Sibai, Mirvat. Metformin Treatment Inhibits Motility and Invasion of Glioblastoma Cancer Cells. Country unknown/Code not available: N. p., 2018. Web. doi:10.1155/2018/5917470.
Al Hassan, Marwa, Fakhoury, Isabelle, El Masri, Zeinab, Ghazale, Noura, Dennaoui, Rayane, El Atat, Oula, Kanaan, Amjad, & El-Sibai, Mirvat. Metformin Treatment Inhibits Motility and Invasion of Glioblastoma Cancer Cells. Country unknown/Code not available. doi:https://doi.org/10.1155/2018/5917470
Al Hassan, Marwa, Fakhoury, Isabelle, El Masri, Zeinab, Ghazale, Noura, Dennaoui, Rayane, El Atat, Oula, Kanaan, Amjad, and El-Sibai, Mirvat. Tue . "Metformin Treatment Inhibits Motility and Invasion of Glioblastoma Cancer Cells". Country unknown/Code not available. doi:https://doi.org/10.1155/2018/5917470.
@article{osti_1457218,
title = {Metformin Treatment Inhibits Motility and Invasion of Glioblastoma Cancer Cells},
author = {Al Hassan, Marwa and Fakhoury, Isabelle and El Masri, Zeinab and Ghazale, Noura and Dennaoui, Rayane and El Atat, Oula and Kanaan, Amjad and El-Sibai, Mirvat},
abstractNote = {Glioblastoma multiforme (GBM) is one of the most common and deadliest cancers of the central nervous system (CNS). GBMs high ability to infiltrate healthy brain tissues makes it difficult to remove surgically and account for its fatal outcomes. To improve the chances of survival, it is critical to screen for GBM-targeted anticancer agents with anti-invasive and antimigratory potential. Metformin, a commonly used drug for the treatment of diabetes, has recently emerged as a promising anticancer molecule. This prompted us, to investigate the anticancer potential of metformin against GBMs, specifically its effects on cell motility and invasion. The results show a significant decrease in the survival of SF268 cancer cells in response to treatment with metformin. Furthermore, metformin’s efficiency in inhibiting 2D cell motility and cell invasion in addition to increasing cellular adhesion was also demonstrated in SF268 and U87 cells. Finally, AKT inactivation by downregulation of the phosphorylation level upon metformin treatment was also evidenced. In conclusion, this study provides insights into the anti-invasive antimetastatic potential of metformin as well as its underlying mechanism of action.},
doi = {10.1155/2018/5917470},
journal = {Analytical Cellular Pathology},
number = ,
volume = 2018,
place = {Country unknown/Code not available},
year = {2018},
month = {6}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record
DOI: https://doi.org/10.1155/2018/5917470

Citation Metrics:
Cited by: 1 work
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Metformin inhibits leptin-induced growth and migration of glioblastoma cells
journal, August 2012

  • Ferla, Rita; Haspinger, Eva; Surmacz, Eva
  • Oncology Letters, Vol. 4, Issue 5
  • DOI: 10.3892/ol.2012.843

Metformin represses cancer cells via alternate pathways in N-cadherin expressing vs. N-cadherin deficient cells
journal, August 2015


Emerging role of plexins signaling in glioma progression and therapy
journal, February 2018


Metformin — a new old drug
journal, August 2017

  • Wróbel, Marta Patrycja; Marek, Bogdan; Kajdaniuk, Dariusz
  • Endokrynologia Polska, Vol. 68, Issue 4
  • DOI: 10.5603/EP.2017.0050

Kefir exhibits anti-proliferative and pro-apoptotic effects on colon adenocarcinoma cells with no significant effects on cell migration and invasion
journal, September 2014

  • Khoury, Nathalie; El-Hayek, Stephany; Tarras, Omayr
  • International Journal of Oncology, Vol. 45, Issue 5
  • DOI: 10.3892/ijo.2014.2635

Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2
journal, April 2016


Glucose-6–phosphatase Is a Key Metabolic Regulator of Glioblastoma Invasion
journal, July 2014


American Brain Tumor Association Adolescent and Young Adult Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
journal, December 2015

  • Ostrom, Quinn T.; Gittleman, Haley; de Blank, Peter M.
  • Neuro-Oncology, Vol. 18, Issue suppl 1
  • DOI: 10.1093/neuonc/nov297

Hallmarks of Cancer: The Next Generation
journal, March 2011


Signaling networks of Rho GTPases in cell motility
journal, October 2013


Temozolomide in combination with metformin act synergistically to inhibit proliferation and expansion of glioma stem-like cells
journal, March 2016

  • Yu, Zhiyun; Zhao, Gang; Li, Pengliang
  • Oncology Letters, Vol. 11, Issue 4
  • DOI: 10.3892/ol.2016.4315

Metformin: an old but still the best treatment for type 2 diabetes
journal, February 2013

  • Rojas, Lilian Beatriz Aguayo; Gomes, Marilia Brito
  • Diabetology & Metabolic Syndrome, Vol. 5, Issue 1
  • DOI: 10.1186/1758-5996-5-6

Brain Cancer Stem Cells in Adults and Children: Cell Biology and Therapeutic Implications
journal, April 2017

  • Abou-Antoun, Tamara J.; Hale, James S.; Lathia, Justin D.
  • Neurotherapeutics, Vol. 14, Issue 2
  • DOI: 10.1007/s13311-017-0524-0

Metformin use improves the survival of diabetic combined small-cell lung cancer patients
journal, May 2015


Regulation of cell adhesion and migration by cell-derived matrices
journal, October 2013

  • Kutys, Matthew L.; Doyle, Andrew D.; Yamada, Kenneth M.
  • Experimental Cell Research, Vol. 319, Issue 16
  • DOI: 10.1016/j.yexcr.2013.05.030

Podosome-type adhesions and focal adhesions, so alike yet so different
journal, September 2008

  • Block, M.; Badowski, C.; Millonfremillon, A.
  • European Journal of Cell Biology, Vol. 87, Issue 8-9
  • DOI: 10.1016/j.ejcb.2008.02.012

StarD13 is a tumor suppressor in breast cancer that regulates cell motility and invasion
journal, March 2014

  • Hanna, Samer; Khalil, Bassem; Nasrallah, Anita
  • International Journal of Oncology, Vol. 44, Issue 5
  • DOI: 10.3892/ijo.2014.2330

Glioma-Initiating Cell Elimination by Metformin Activation of FOXO3 via AMPK
journal, November 2012

  • Sato, Atsushi; Sunayama, Jun; Okada, Masashi
  • STEM CELLS Translational Medicine, Vol. 1, Issue 11
  • DOI: 10.5966/sctm.2012-0058

Molecular Pathways: Preclinical Models and Clinical Trials with Metformin in Breast Cancer
journal, March 2014


Metformin and Ara-a Effectively Suppress Brain Cancer by Targeting Cancer Stem/Progenitor Cells
journal, November 2015

  • Mouhieddine, Tarek H.; Nokkari, Amaly; Itani, Muhieddine M.
  • Frontiers in Neuroscience, Vol. 9
  • DOI: 10.3389/fnins.2015.00442

Exploring the role of metformin in anticancer treatments: A systematic review
journal, January 2014


Dimethylbiguanide Inhibits Cell Respiration via an Indirect Effect Targeted on the Respiratory Chain Complex I
journal, January 2000

  • El-Mir, Mohamad-Yehia; Nogueira, Véronique; Fontaine, Eric
  • Journal of Biological Chemistry, Vol. 275, Issue 1
  • DOI: 10.1074/jbc.275.1.223

Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner
journal, October 2009


Cancer stem cells in glioblastoma
journal, June 2015

  • Lathia, Justin D.; Mack, Stephen C.; Mulkearns-Hubert, Erin E.
  • Genes & Development, Vol. 29, Issue 12
  • DOI: 10.1101/gad.261982.115

Differential sensitivities of glioblastoma cell lines towards metabolic and signaling pathway inhibitions
journal, August 2013


Metformin: clinical use in type 2 diabetes
journal, August 2017


Glioblastoma and Other Malignant Gliomas: A Clinical Review
journal, November 2013


Cisplatin Combined with Metformin Inhibits Migration and Invasion of Human Nasopharyngeal Carcinoma Cells by Regulating E-cadherin and MMP-9
journal, May 2014


Metformin: A Potential Therapeutic Agent for Recurrent Colon Cancer
journal, January 2014


Invadopodia, Regulation, and Assembly in Cancer Cell Invasion
journal, June 2014


Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt
journal, January 2013

  • Würth, Roberto; Pattarozzi, Alessandra; Gatti, Monica
  • Cell Cycle, Vol. 12, Issue 1
  • DOI: 10.4161/cc.23050

Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
journal, June 2013


Metformin Inhibits Growth of Human Glioblastoma Cells and Enhances Therapeutic Response
journal, April 2015


CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009–2013
journal, October 2016

  • Ostrom, Quinn T.; Gittleman, Haley; Xu, Jordan
  • Neuro-Oncology, Vol. 18, Issue suppl_5
  • DOI: 10.1093/neuonc/now207

Metformin Is an AMP Kinase–Dependent Growth Inhibitor for Breast Cancer Cells
journal, October 2006


Metformin inhibits glioma cell U251 invasion by downregulation of fibulin-3
journal, January 2013


Rho GTPases in primary brain tumor malignancy and invasion
journal, April 2012


Metformin inhibits the development and metastasis of ovarian cancer
journal, June 2012


Effect of metformin on the human T98G glioblastoma multiforme cell line
journal, March 2014

  • Ucbek, Alİ; ÖZÜNal, Zeynep GÜNeŞ; Uzun, ÖZge
  • Experimental and Therapeutic Medicine, Vol. 7, Issue 5
  • DOI: 10.3892/etm.2014.1597

Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis
journal, April 2007

  • Isakovic, A.; Harhaji, L.; Stevanovic, D.
  • Cellular and Molecular Life Sciences, Vol. 64, Issue 10
  • DOI: 10.1007/s00018-007-7080-4

Metformin against Cancer Stem Cells through the Modulation of Energy Metabolism: Special Considerations on Ovarian Cancer
journal, January 2014

  • Kim, Tae Hun; Suh, Dong Hoon; Kim, Mi-Kyung
  • BioMed Research International, Vol. 2014
  • DOI: 10.1155/2014/132702

Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
journal, July 2010

  • Foretz, Marc; Hébrard, Sophie; Leclerc, Jocelyne
  • Journal of Clinical Investigation, Vol. 120, Issue 7
  • DOI: 10.1172/JCI40671

The mechanisms of action of metformin
journal, August 2017


Metformin treatment reduces temozolomide resistance of glioblastoma cells
journal, October 2016